Fresh Tracks Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Fresh Tracks Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 300M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 300M 0 0% Dec 31, 2023 10-K 2024-03-15
Q3 2023 300M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 300M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 300M 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 300M 0 0% Dec 31, 2022 10-K 2024-03-15
Q3 2022 300M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 300M 0 0% Jun 30, 2022 10-Q/A 2022-09-01
Q1 2022 300M +200M +200% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 300M +200M +200% Dec 31, 2021 10-K 2023-03-30
Q3 2021 300M +200M +200% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 300M +250M +500% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 100M +50M +100% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 100M +50M +100% Dec 31, 2020 10-K 2022-03-15
Q3 2020 100M +50M +100% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 50M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 50M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 50M +42M +525% Dec 31, 2019 10-K 2021-03-09
Q3 2019 50M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 50M 0 0% Jun 30, 2019 10-Q 2019-07-12
Q1 2019 50M 0 0% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 8M -42M -84% Dec 31, 2018 10-K 2020-03-18
Q3 2018 50M 0 0% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 50M 0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 50M -110M -68.8% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 50M 0 0% Dec 31, 2017 10-K 2019-03-01
Q3 2017 50M -110M -68.8% Sep 30, 2017 10-Q 2017-10-24
Q2 2017 50M -110M -68.8% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 160M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 50M -110M -68.8% Dec 31, 2016 10-K 2018-03-15
Q3 2016 160M 0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 160M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 160M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 160M 0 0% Dec 31, 2015 10-K 2017-03-10
Q3 2015 160M 0 0% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 160M 0 0% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 160M 0 0% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 160M 0 0% Dec 31, 2014 10-K 2016-03-14
Q3 2014 160M 0 0% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 160M 0 0% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 160M 0 0% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 160M 0 0% Dec 31, 2013 10-K 2015-02-26
Q3 2013 160M 0 0% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 160M 0 0% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 160M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 160M 0 0% Dec 31, 2012 10-K 2014-02-14
Q3 2012 160M 0 0% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 160M 0 0% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 160M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 160M 0 0% Dec 31, 2011 10-K 2013-02-15
Q3 2011 160M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 160M Jun 30, 2011 10-Q 2011-08-03
Q4 2010 160M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.